Epigenetic regulation of Epstein-Barr virus: From bench to bedside

被引：0

作者：

Gao, Xiao ^{[1
]}

Yang, Hao-Xu ^{[1
]}

Cheng, Shu ^{[1
]}

Cai, Hua-Man ^{[1
]}

Xiong, Jie ^{[1
]}

Zhao, Wei-Li ^{[1
,2
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai, Ruijin Hosp,State Key Lab Med Genom,Sch Med, Shanghai, Peoples R China

[2] Lab Mol Pathol, Pole Rech Sinofrancais Sci Vivant et Genom, Shanghai, Peoples R China

来源：

CLINICAL AND TRANSLATIONAL DISCOVERY | 2024年 / 4卷 / 05期

基金：

中国国家自然科学基金;

关键词：

epigenetic; Epstein-Barr virus; histone; immune escape; metabolic reprogramming; pathogenesis; targeted therapy; NK/T-CELL LYMPHOMA; NASOPHARYNGEAL CARCINOMA; PRIMARY IMMUNODEFICIENCIES; GENE-EXPRESSION; PHASE-II; PROTEIN; TRANSCRIPTION; REVEALS; REACTIVATION; PROMOTERS;

D O I：

10.1002/ctd2.357

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

BackgroundEpstein-Barr virus (EBV) is a double-stranded DNA herpesvirus and establishes life-long infection in 95% of the world's populations.Main bodyEBV is critically involved in multiple diseases. Aberrant signaling pathways, immune escape, and metabolic reprogramming play essential roles in EBV-mediated pathogenesis. However, the underlying mechanisms have not yet been fully elucidated. Here we reviewed recent advances on the epigenetic regulation of EBV pathogenesis, which may translate to potential therapeutic strategies in EBV-associated diseases.ConclusionGrowing evidence has suggested that viral infections reconstruct epigenome to modulate gene expression both in the host and the virus levels. EBV acts as an epigenetic driver in carcinogenesis and mainly refers to DNA methylation, RNA methylation, histone modification, chromatin accessibility, and the three-dimensional (3D) genome structure. image

引用

页数：13

共 50 条

[41] Epstein-Barr virus infection and nasopharyngeal carcinoma: the other side of the coin
Perri, Francesco
Scarpati, Giuseppina Della Vittoria
Giuliano, Mario
D'Aniello, Carmine
Gnoni, Antonio
Cavaliere, Carla
Licchetta, Antonella
Pisconti, Salvatore
ANTI-CANCER DRUGS, 2015, 26 (10) : 1017 - 1025
[42] Epstein-Barr Virus Infection of Oral Squamous Cells
Heawchaiyaphum, Chukkris
Iizasa, Hisashi
Ekalaksananan, Tipaya
Burassakarn, Ati
Kiyono, Tohru
Kanehiro, Yuichi
Yoshiyama, Hironori
Pientong, Chamsai
MICROORGANISMS, 2020, 8 (03)
[43] Genetics of Epstein-Barr virus microRNAs
Klinke, Olaf
Feederle, Regina
Delecluse, Henri-Jacques
SEMINARS IN CANCER BIOLOGY, 2014, 26 : 52 - 59
[44] Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin
Chung-Chun Wu
Chih-Yeu Fang
Yu-Jhen Cheng
Hui-Yu Hsu
Sheng-Ping Chou
Sheng-Yen Huang
Ching-Hwa Tsai
Jen-Yang Chen
Journal of Biomedical Science, 24
[45] Epstein-Barr virus-associated cellular immunotherapy
Zhang, Yi
Lyu, Hairong
Guo, Ruiting
Cao, Xinping
Feng, Juan
Jin, Xin
Lu, Wenyi
Zhao, Mingfeng
CYTOTHERAPY, 2023, 25 (09) : 903 - 912
[46] Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma
Niedobitek, G
PATHOLOGE, 1998, 19 (05): : 337 - 344
[47] The Microenvironment in Epstein-Barr Virus-Associated Malignancies
Tan, Geok Wee
Visser, Lydia
Tan, Lu Ping
van den Berg, Anke
Diepstra, Arjan
PATHOGENS, 2018, 7 (02)
[48] Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection
Bauer, CC
Aberle, SW
Popow-Kraupp, T
Kapitan, M
Hofmann, H
Puchhammer-Stöckl, E
JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (01) : 54 - 58
[49] Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia
Niller, Hans Helmut
Wolf, Hans
Minarovits, Janos
SEMINARS IN CANCER BIOLOGY, 2009, 19 (03) : 158 - 164
[50] Stress-Induced Epstein-Barr Virus Reactivation
Sausen, Daniel G.
Bhutta, Maimoona S.
Gallo, Elisa S.
Dahari, Harel
Borenstein, Ronen
BIOMOLECULES, 2021, 11 (09)

← 1 2 3 4 5 →